BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20702590)

  • 1. Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary human B cells.
    Lu H; Crawford RB; Suarez-Martinez JE; Kaplan BL; Kaminski NE
    Toxicol Sci; 2010 Nov; 118(1):86-97. PubMed ID: 20702590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
    Sulentic CE; Holsapple MP; Kaminski NE
    J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Sulentic CE; Kaminski NE
    Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S171-91. PubMed ID: 20952503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
    Sulentic CE; Holsapple MP; Kaminski NE
    Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells.
    Kovalova N; Nault R; Crawford R; Zacharewski TR; Kaminski NE
    Toxicol Appl Pharmacol; 2017 Feb; 316():95-106. PubMed ID: 27913140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of aryl hydrocarbon receptor polymorphisms on TCDD-mediated CYP1B1 induction and IgM suppression by human B cells.
    Kovalova N; Manzan M; Crawford R; Kaminski N
    Toxicol Appl Pharmacol; 2016 Oct; 309():15-23. PubMed ID: 27535091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of the IgM Response by Aryl Hydrocarbon Receptor Activation in Human Primary B Cells Involves Impairment of Immunoglobulin Secretory Processes.
    Zhou J; Henriquez J; Crawford R; Kaminski N
    Toxicol Sci; 2018 May; 163(1):319-329. PubMed ID: 29462421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCDD-mediated suppression of naïve human B cell IgM secretion involves aryl hydrocarbon receptor-mediated reduction in STAT3 serine 727 phosphorylation and is restored by interferon-γ.
    Blevins LK; Zhou J; Crawford R; Kaminski NE
    Cell Signal; 2020 Jan; 65():109447. PubMed ID: 31678681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis.
    Li J; Phadnis-Moghe AS; Crawford RB; Kaminski NE
    Toxicology; 2017 Mar; 378():17-24. PubMed ID: 28049042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
    Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
    Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
    Phadnis-Moghe AS; Crawford RB; Kaminski NE
    Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing Serpinb2 as a Modulator of TCDD-Induced Suppression of the B Cell.
    Dornbos P; Warren M; Crawford RB; Kaminski NE; Threadgill DW; LaPres JJ
    Chem Res Toxicol; 2018 Nov; 31(11):1248-1259. PubMed ID: 30339366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte-Specific Protein Tyrosine Kinase (LCK) is Involved in the Aryl Hydrocarbon Receptor-Mediated Impairment of Immunoglobulin Secretion in Human Primary B Cells.
    Zhou J; Zhang Q; Henriquez JE; Crawford RB; Kaminski NE
    Toxicol Sci; 2018 Oct; 165(2):322-334. PubMed ID: 29860352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation.
    Ahrenhoerster LS; Tate ER; Lakatos PA; Wang X; Laiosa MD
    Toxicol Appl Pharmacol; 2014 Jun; 277(2):172-82. PubMed ID: 24709672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional activation of arylhydrocarbon receptor (AhR) in primary T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Doi H; Baba T; Tohyama C; Nohara K
    Chemosphere; 2003 Jul; 52(4):655-62. PubMed ID: 12738279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
    Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
    Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological characterization of the aryl hydrocarbon receptor (AHR) knockout rat in the presence and absence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Phadnis-Moghe AS; Chen W; Li J; Crawford RB; Bach A; D'Ingillo S; Kovalova N; Suarez-Martinez JE; Kaplan BL; Harrill JA; Budinsky R; Rowlands JC; Thomas RS; Kaminski NE
    Toxicology; 2016 Aug; 368-369():172-182. PubMed ID: 27590929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCDD-induced expression of Ah receptor responsive genes in the pituitary and brain of cellular retinol-binding protein (CRBP-I) knockout mice.
    Huang P; Ceccatelli S; Hoegberg P; Sten Shi TJ; Håkansson H; Rannug A
    Toxicol Appl Pharmacol; 2003 Nov; 192(3):262-74. PubMed ID: 14575644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD.
    Kerkvliet NI; Shepherd DM; Baecher-Steppan L
    Toxicol Appl Pharmacol; 2002 Dec; 185(2):146-52. PubMed ID: 12490139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Sensitive Human Immunological Target of Aryl Hydrocarbon Receptor Activation: CD5
    Blevins LK; Zhou J; Crawford RB; Kaminski NE
    Front Immunol; 2021; 12():635748. PubMed ID: 33936048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.